These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 646588)

  • 1. [The simplex-method for optimizing tablet formulations in practical experience (author's transl)].
    Beyer C
    Arch Pharm (Weinheim); 1978 Feb; 311(2):128-31. PubMed ID: 646588
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of formation of an hydrophilic and continuous network of starch on tablet properties. III. Investigation on mathematical determination of the best starch concentration which garantee the best level of bioavailability from tablets (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(4):204-11. PubMed ID: 501514
    [No Abstract]   [Full Text] [Related]  

  • 3. How suitable is the measurement of take-off forces for detection of sticking during direct compression of various ibuprofen tablet formulations?
    Saniocki I; Sakmann A; Leopold CS
    Pharm Dev Technol; 2013 Feb; 18(1):257-65. PubMed ID: 22931059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging elevated temperature and particle size reduction to extract API from various tablet formulations.
    Nickerson B; Arikpo WB; Berry MR; Bobin VJ; Houck TL; Mansour HL; Warzeka J
    J Pharm Biomed Anal; 2008 Jun; 47(2):268-78. PubMed ID: 18280688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tablet splitting].
    Quinzler R; Haefeli WE
    Ther Umsch; 2006 Jun; 63(6):441-7. PubMed ID: 16841582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of formation of an hydrophilic and continuous network of starch on tablets properties. II. Repercussion on tablets characteristics, depending on conditions of the compression (author's transl)].
    Ringard J; Guyot-Hermann AM
    J Pharm Belg; 1979; 34(3):175-82. PubMed ID: 480129
    [No Abstract]   [Full Text] [Related]  

  • 7. The reality of in-line tablet coating.
    Cahyadi C; Chan LW; Heng PW
    Pharm Dev Technol; 2013 Feb; 18(1):2-16. PubMed ID: 21649557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tablets formulation from standardized citroflavenoids and study of presentation (author's transl)].
    Pourrat A; Renoux R; Jean D
    Ann Pharm Fr; 1978; 36(5-6):253-62. PubMed ID: 707954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formulation study of phenacetin tablets by direct compression (author's transl)].
    Tshimpangila D; Delattre L
    J Pharm Belg; 1980; 35(5):357-63. PubMed ID: 7452441
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of extraction techniques for spray dried dispersion tablet formulations.
    Lee C; Gallo J; Arikpo W; Bobin V
    J Pharm Biomed Anal; 2007 Nov; 45(4):565-71. PubMed ID: 17888606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of the granulation process for designing tablets.
    Miyamoto Y; Ryu A; Sugawara S; Miyajima M; Matsui M; Takayama K; Nagai T
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1432-7. PubMed ID: 9775438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the behaviour of a one-component drug form during compression (author's transl)].
    Welikowa E; Dinev P
    Pharmazie; 1981; 36(2):130-3. PubMed ID: 7232484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets.
    Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M
    Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 5th Part: Bioavailability of Riboflavin enteric coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(4):341-54. PubMed ID: 978382
    [No Abstract]   [Full Text] [Related]  

  • 16. [Equipments and aqueous coating procedures with low viscosity HPMC at laboratory scale (author's transl)].
    Delporte JP; De Seille JM; Jaminet F
    J Pharm Belg; 1981; 36(5):337-47. PubMed ID: 7310628
    [No Abstract]   [Full Text] [Related]  

  • 17. Manufacturing of Multi-drug Formulations with Customised Dose by Solvent Impregnation of Mesoporous Silica Tablets.
    Šoltys M; Akhlasová S; Zadražil A; Kovačík P; Štěpánek F
    AAPS PharmSciTech; 2019 Jan; 20(1):25. PubMed ID: 30604137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulation of tablet motion in coating drum.
    Yamane K; Sato T; Tanaka T; Tsuji Y
    Pharm Res; 1995 Sep; 12(9):1264-8. PubMed ID: 8570518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent structure analysis in the pharmaceutical process of tablets prepared by wet granulation.
    Uehara N; Hayashi Y; Mochida H; Otoguro S; Onuki Y; Obata Y; Takayama K
    Drug Dev Ind Pharm; 2016 Jan; 42(1):116-122. PubMed ID: 25997364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs.
    Zaheer K; Langguth P
    Eur J Pharm Biopharm; 2019 Jun; 139():177-185. PubMed ID: 30902732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.